PMID: 6171188Jan 1, 1981Paper

A 5 consecutive day combination of CIS platinum and bleomycin in squamous cell bronchial carcinoma (author's transl)

Annales de médecine interne
L IsraelJ P Battesti

Abstract

Twenty patients with inoperable squamous cell carcinoma of the lung (14 previously untreated and 6 previously treated) received a combination of bleomycin and cis-platinum for 6 consecutive days every 3 or 4 weeks. Pulmonary toxicity was minimal with only one case of reversible bleomycin-induced acute interstitial pneumopathy. The response rate was 65 p.cent. Thirteen patients had an objective response, including 5 apparently complete regressions. All responders were previously untreated patients. The results are discussed in the light of pharmacokinetic and cell kinetic data, and lead to a proposal for a non-conventional combined approach in squamous cell carcinoma of the lung, hitherto relatively unresponsive to chemotherapy.

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.